Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03866382 |
| Title | Cabozantinib in Combination With Nivolumab and Ipilimumab in Rare Genitourinary Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | National Cancer Institute (NCI) |
| Indications |
papillary renal cell carcinoma sarcomatoid transitional cell carcinoma urinary bladder small cell neuroendocrine carcinoma bladder squamous cell carcinoma |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |